Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021.

ABSTRACT:

Background

Oral HIV pre-exposure prophylaxis (PrEP) has been available and fully reimbursed for people at high risk of sexually acquired HIV infection in France since January 2016. Its dissemination has been widely promoted to reduce HIV incidence in high-risk populations. This study aimed to assess the roll-out of PrEP use in France from its implementation until mid-2021.

Methods

Using the French National Health Data System (SNDS) covering 99% of people residing in France, all PrEP users defined as individuals aged 15 years or older who received at least one dispensing of PrEP between 1 January 2016 and 30 June 2021 were identified. PrEP users number and their socio-demographic and PrEP use characteristics were assessed over time.

Findings

As of 30 June 2021, a total

SUBMITTER: Billioti de Gage S 

PROVIDER: S-EPMC9386455 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature